Optimi HealthTM is developing a Canadian vertically integrated functional mushroom brand that focuses on the health and wellness food markets. The Company also intends to cultivate, extract, process and distribute high quality strains of fungi products at its Facilities located in Princeton, British Columbia.
In addition, the Company received a Research Exemption in January 2021 and applied for a Dealer’s License in November 2020 through its wholly owned subsidiary Optimi Labs relating to the use and scientific research on psilocybin mushrooms and the possession, distribution, sale, laboratory analysis of and research and development in respect of psilocybin.
Read our Corporate Highlights here
Optimi Health Corp.
330 – 1122 Mainland Street
Vancouver BC V6B 5L1
Investor Relations:
Email: investors@optimihealth.ca
Phone: +1 (778) 930-1321
Trading Symbol: CSE: OPTI | OTC:OPTHF | FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding (03/26/21): 69,063,006
Incorporated – BC / May 27, 2020
Year End – September 30th
Miller Thomson LLP
www.millerthomson.com
Smythe CPA
www.smythecpa.com
Endeavor Trust
Corporation
www.endeavortrust.com
SEDAR (System for Electronic Document Analysis and Retrieval)
